MARKET

ENZ

ENZ

Enzo Biochem Inc
NYSE
1.150
+0.010
+0.88%
Closed 15:59 07/26 EDT
OPEN
1.120
PREV CLOSE
1.140
HIGH
1.155
LOW
1.120
VOLUME
53.74K
TURNOVER
0
52 WEEK HIGH
1.890
52 WEEK LOW
0.9901
MARKET CAP
59.18M
P/E (TTM)
-4.5744
1D
5D
1M
3M
1Y
5Y
1D
Enzo Biochem Enhances CFO Patricia Eckert’s Compensation Package
TipRanks · 1d ago
Weekly Report: what happened at ENZ last week (0715-0719)?
Weekly Report · 4d ago
Enzo Biochem: Is This Time Finally Different?
Enzo Biochem's stock is trading near historic lows. Stock has potential for attractive returns with simplified Life Sciences division and strong CEO incentives. Company has $35m in cash after sale of Clinical Labs business to Labcorp Holdings. New CEO has been granted calls with a strike at $2 a share. Valuation potential of $2.00-3.22/share with $75-120m business value.
Seeking Alpha · 07/17 04:49
Weekly Report: what happened at ENZ last week (0708-0712)?
Weekly Report · 07/15 09:25
Weekly Report: what happened at ENZ last week (0701-0705)?
Weekly Report · 07/08 09:26
Weekly Report: what happened at ENZ last week (0624-0628)?
Weekly Report · 07/01 09:26
Weekly Report: what happened at ENZ last week (0617-0621)?
Weekly Report · 06/24 09:27
Enzo Biochem Third Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.16 loss in 3Q 2023)
Enzo Biochem shares are down 9.2% from a week ago. The company reported a loss of US$2.13m in the third quarter of 2024. The stock is down 10% from its highs in the last week. There are 3 warning signs for Enzo biochem.
Simply Wall St · 06/19 10:58
More
About ENZ
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

Webull offers Enzo Biochem Inc stock information, including NYSE: ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.